Goyal Vikas
Insider CIK 1721017 · MORF Director · SPRO Director · PAND See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 28,227 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 73,789 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 87,764 | $60.00 | $5.27M | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | P Buy | 2021-03-05 | 2021-03-08 | 1,000 | $70.00 | $70.0K | 1,000 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2021-02-08 | 2021-02-10 | 73,789 | — | $0 | 73,789 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 35,922 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 7,044 | — | $0 | 86,314 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 1,450 | $18.00 | $26.1K | 87,764 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 10,486 | — | $0 | 10,486 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 13,935 | — | $0 | 13,935 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 3,806 | — | $0 | 3,806 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2019-08-01 | 2019-08-02 | 24,000 | — | $0 | 24,000 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion deriv | 2019-07-01 | 2019-07-01 | 830,489 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion deriv | 2019-07-01 | 2019-07-01 | 1,469,950 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | P Buy | 2019-07-01 | 2019-07-01 | 333,333 | $15.00 | $5.00M | 2,633,772 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion | 2019-07-01 | 2019-07-01 | 830,489 | — | $0 | 2,300,439 | SEC↗ |
| MORF Morphic Holding, Inc. | C Conversion | 2019-07-01 | 2019-07-01 | 1,469,950 | — | $0 | 1,469,950 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 3,683,045 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 982,906 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 1,483,784 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 1,250,000 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 244,147 | — | $0 | 244,147 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 246,272 | — | $0 | 490,419 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 328,992 | — | $0 | 819,411 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 606,024 | — | $0 | 1,425,435 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | P Buy | 2017-11-06 | 2017-11-07 | 428,571 | $14.00 | $6.00M | 1,854,006 | SEC↗ |